NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 241 filers reported holding NOVOCURE LTD in Q3 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $409 | +65.6% | 23,868 | +51.3% | 0.00% | – |
Q1 2024 | $247 | +9.8% | 15,774 | +4.7% | 0.00% | – |
Q4 2023 | $225 | -7.4% | 15,068 | -0.0% | 0.00% | -100.0% |
Q3 2023 | $243 | -58.5% | 15,073 | +6.8% | 0.00% | 0.0% |
Q2 2023 | $586 | -39.6% | 14,114 | -12.6% | 0.00% | -50.0% |
Q1 2023 | $971 | -19.2% | 16,151 | -1.4% | 0.00% | -33.3% |
Q4 2022 | $1,201 | -99.9% | 16,377 | +21.0% | 0.00% | 0.0% |
Q3 2022 | $1,028,000 | +9.7% | 13,532 | +0.3% | 0.00% | +50.0% |
Q2 2022 | $937,000 | -37.7% | 13,486 | -25.7% | 0.00% | -33.3% |
Q1 2022 | $1,503,000 | +10.9% | 18,147 | +0.6% | 0.00% | 0.0% |
Q4 2021 | $1,355,000 | -38.9% | 18,046 | -5.5% | 0.00% | -50.0% |
Q3 2021 | $2,219,000 | -51.5% | 19,105 | -7.4% | 0.01% | -45.5% |
Q2 2021 | $4,578,000 | +81.5% | 20,638 | +8.1% | 0.01% | +57.1% |
Q1 2021 | $2,522,000 | -22.5% | 19,083 | +1.5% | 0.01% | -22.2% |
Q4 2020 | $3,253,000 | -49.1% | 18,802 | -67.3% | 0.01% | -10.0% |
Q3 2020 | $6,392,000 | +91.7% | 57,428 | +2.1% | 0.01% | +66.7% |
Q2 2020 | $3,334,000 | +77.6% | 56,232 | +101.7% | 0.01% | -40.0% |
Q1 2020 | $1,877,000 | -17.3% | 27,873 | +3.5% | 0.01% | +11.1% |
Q4 2019 | $2,269,000 | +16.3% | 26,920 | +3.2% | 0.01% | 0.0% |
Q3 2019 | $1,951,000 | +18.7% | 26,090 | +0.3% | 0.01% | +12.5% |
Q2 2019 | $1,644,000 | +49.0% | 26,002 | +13.6% | 0.01% | +60.0% |
Q1 2019 | $1,103,000 | +47.3% | 22,891 | +2.4% | 0.01% | +25.0% |
Q4 2018 | $749,000 | -24.8% | 22,359 | +17.6% | 0.00% | -20.0% |
Q3 2018 | $996,000 | +77.5% | 19,014 | +6.1% | 0.01% | +66.7% |
Q2 2018 | $561,000 | +34.2% | 17,925 | -6.4% | 0.00% | +50.0% |
Q1 2018 | $418,000 | +15.8% | 19,152 | +7.2% | 0.00% | 0.0% |
Q4 2017 | $361,000 | -5.5% | 17,874 | -7.0% | 0.00% | 0.0% |
Q3 2017 | $382,000 | +20.1% | 19,224 | +4.7% | 0.00% | 0.0% |
Q2 2017 | $318,000 | – | 18,366 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |